Individuals with the CT genotype had lower hypertension risk, systolic blood pressure, blood glucose, and plasma MDA levels than those with the CC genotype, suggesting that the PPARD rs7770619 SNP could be a potential candidate gene for hypertension [248]
boron3
[DOI] [PMC free article] [PubMed] [Google Scholar] (332).Rabuka D
The cardiometabolic data also reinforce the emerging understanding that incretin-based therapies produce benefits beyond weight loss itself likely through direct receptor-mediated effects on hepatic metabolism, vascular inflammation, and lipid handling
Schusdziarra, V., Dobbs, R
If you are still unsure which fits your specific profile, our quiz can provide a personalized recommendation based on your lifestyle and health history